Bristol-Myers Squibb Co.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2025
Total Assets: $90.04B
Liabilities Breakdown FY2025
Total Liabilities: $71.53B
Asset Breakdown
Total Assets: $90.04B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $10.21B | 11.3% |
| Accounts Receivable | $9.59B | 10.7% |
| Inventory | $2.69B | 3.0% |
| Property, Plant & Equipment | $7.54B | 8.4% |
| Goodwill | $21.75B | 24.2% |
| Intangible Assets | $19.10B | 21.2% |
| Other Assets | $19.15B | 21.3% |
Liabilities Breakdown
Total Liabilities: $71.53B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.58B | 5.0% |
| Long-Term Debt | $42.85B | 59.9% |
| Other Liabilities | $25.11B | 35.1% |